Individualizing Therapeutic Options and Achieving Goals in Chronic Lymphocytic Leukemia (CLL)


Module 1
New Kinase Inhibitors in CLL – Jan A. Burger, MD, PhD

Begin


Module 2
Prognostic and Predictive Factors in CLL – Thomas J. Kipps, MD, PhD

Begin


Module 3
The Value of Traditional Chemotherapy – Peter Hillmen, MD, FRCP, FRCPath, PhD

Begin


Module 4
Changing Future Treatment Paradigms: The Role of Novel Therapies – Jennifer R. Brown, MD, PhD

Begin


Module 5
Case Review – Jan A. Burger, MD, PhD

Begin


Supplemental Module
Supplemental Faculty Insight – Questions and Answers

Begin